Understanding the RNA changes that lead to congenital myotonic dystrophy
Identifying the RNA Splicing and Gene Expression Changes that Cause Congenital Myotonic Dystrophy (Renewal)
This study is looking at how congenital myotonic dystrophy affects kids' muscles from birth to age 16 by examining muscle samples to see how changes in genes relate to their symptoms, with the hope of finding better ways to diagnose and treat the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Commonwealth University NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project ID | NIH-10882023 on NIH RePORTER |
What this research studies
This research investigates congenital myotonic dystrophy, a severe condition that affects muscle function and development from birth. The team will analyze RNA splicing and gene expression changes in muscle biopsies from affected individuals aged 0 to 16 years to understand how these changes correlate with the symptoms experienced at different ages. By studying over 100 children, the researchers aim to uncover the mechanisms behind the varying severity of symptoms throughout development. This could lead to better diagnostic and therapeutic strategies for managing the condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with congenital myotonic dystrophy, particularly those between the ages of 0 and 16.
Not a fit: Patients with other forms of myotonic dystrophy or those outside the specified age range may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for congenital myotonic dystrophy, enhancing the quality of life for affected individuals.
How similar studies have performed: Previous research has shown promising results in understanding RNA splicing in myotonic dystrophy, indicating that this approach may yield valuable insights.
Where this research is happening
Richmond, United States
- Virginia Commonwealth University — Richmond, United States (Active)
Researchers
- Principal investigator: Johnson, Nicholas Elwood — Virginia Commonwealth University
- Study coordinator: Johnson, Nicholas Elwood
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.